S2-E31.1 - Previewing Digital ILC 2021 -- Part II -- "Favorite Things" and Discussing Metabolic issues

Send us a text

Jörn Schattenberg and the regular Surfers identify one thing about the Digital ILC 2021 meeting they anticipate eagerly and fall into a discussion about pharmacologic and non-pharmacologic approaches to managing metabolic issues.

As the group looked forward to Digital ILC 2021, each panelist identified one source of particular excitement. The answers varied all the way from process (enough time for interaction between speakers) to session themes to individual pieces of content. In the end, discussion of a NAFLD Therapy abstract session served as a springboard to a broader discussion about different ways to reduce or resolve steatohepatitis regardless of effect on fibrosis. The end of the discussion focused on the under-appreciated issue of omega-oil types found in diet.